Stem Cell Innovations, a cell biology company, has filed a new patent application for the production of pluripotent stem cells from primordial germ cells. The company has been developing PluriCells for use in drug discovery.
Subscribe to our email newsletter
James Kelly, CEO of Stem Cell Innovations, said: “We have been working for several years to develop a more effective method for producing stem cells from germ cells. This filing was submitted to secure our intellectual property prior to publication in the scientific literature.
“The method in this application provides for a substantial improvement in both the yield and quality of stem cells produced. It builds on our already strong IP position in germ cell-derived stem cells and will allow us to expand in new directions.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.